NR507 Week 5 Discussion: Clinical Management of Guillain-Barré Syndrome

Order ready-to-submit essays - 100% plagiarism-free guaranteed!

Note: Our papers are 100% human-written. 

Clinical Management of Guillain-Barre Syndrome

            Guillain-Barré Syndrome (GBS) is a rare autoimmune disorder whereby the immune system attacks the peripheral nerve system, leading to paralysis and muscular weakness, among others, and possible failure of the breathing system. Studies point to the infection by Campylobacter jejuni, cytomegalovirus (CMV), and Epstein-Barr virus (EBV), or some post-vaccination related reactions, usually being the root cause of the disease (Oshomoji et al., 2024). The initial symptoms of this autoimmune disease are sensory dysfunctions and locomotor weakness of the legs that emerge within a short period and cover the whole body.

In the case of weak deep tendon reflexes, they will slowly disappear, although in a more serious disease, there is a problem in swallowing, paralysis of the face, autonomic dysfunction, i.e., a drop in blood pressure, and heart arrhythmias. The combination of body immobility with chronic neuropathic pain leads to the development of deep vein thrombosis (DVT) in many GBS patients and later may turn into irreversible disability (Singh et al., 2023). Recent infections and a history of autoimmune diseases, as well as older age groups, predispose patients to GBS; older people are more likely to have negative manifestations of the disease.

GBS diagnosis should be done through confirmatory testing and clinical manifestation. A lumbar puncture will show albumin-cytologic dissociation through cerebrospinal fluid (CSF), with normal numbers of white blood cells, but with high levels of proteins. Nerve conduction studies and electromyography tests show that the axonal damage and demyelination cause slow signal speed in patients (Berciano, 2020).

Medical professionals also conduct magnetic resonance imaging scans on the spine in order to diagnose other neurological-related conditions; however, the scan never confirms the diagnosis of GBS. As the presence of anti-GM1 (and other anti-GBS variants) in blood indicates some forms of GBS, medical practitioners seek them (Granito et al., 2021). Hospitalization at an early age is vital since autonomic dysfunction and respiratory issues should be tracked and addressed extremely early.

The symptoms of GBS have various forms depending on the age groups of patients as well as the biological condition of each patient. Children and babies rarely have GBS following a viral infection that causes walking disability, irritability and weakness in the lower part of the body (Bhagwat et al., 2024). Children are generally able to overcome GBS better than adult patients. The GBS may manifest itself during pregnancy either in the antenatal period or postpartum and lead to complications, including preterm labor, because of autonomic instability (Chen et al., 2024).

Although GBS, on its part, has no direct impact on breastfeeding, extreme maternal weakness might negatively interfere with the capability to take care of the baby. The patient may have a greater risk of respiratory failure and slow recovery in older adulthood as the disease is more severe. Neuropathic symptoms are long-lasting among many elderly patients, and they need long periods in rehabilitation.

Michael Roberts, a 42-year-old IT employee, presented to the emergency room three days ago, complaining of tingling sensations and bilateral weakness of limbs that had been progressively getting worse. Although he has no records of recent travel or chronic illnesses, he merely has a stomach ailment that is two weeks old. The outcome of the examination is that he is deficient in three out of five of the lower body muscles, and the knee and ankle have no deep tendon reflexes whatsoever. His speech is blurred, and his facial muscles of the face are moderately weak, with his vital signs showing that his heart is racing (110 bpm) and his blood pressure is not stable.

The results of a nerve conduction study, which indicate the decrease in conduction velocities and the increase in protein levels (120 mg/dL) and normal white blood cell count, suggest the presence of a demyelinating polyneuropathy. Having got Guillain-Barré Syndrome, he was taken to the intensive care and observed by the professionals. Besides supportive physical therapy and prevention of DVT, the patient is treated with IVIG. The recovery stage of Michael takes a period of weeks, and he experiences less fatigue and slight neuropathy that requires continual rehabilitation treatment. They will eliminate life-threatening emergencies such as respiratory failure, and early diagnosis and aggressive medical treatments are essential.